Scarica l'app Stockscreener
19.23
0.44%
-0.085
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KVUE Giù?
Forum
Previsione
Storia dei dividendi
Kenvue Inc Borsa (KVUE) Ultime notizie
Maverick Capital Ltd. Buys Shares of 92,009 Kenvue Inc. $KVUE - MarketBeat
Polar Asset Management Partners Inc. Lowers Position in Kenvue Inc. $KVUE - MarketBeat
Lazard Asset Management LLC Trims Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc (KVUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Kenvue Inc (KVUE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kenvue Inc. stock rises Monday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Balance Sheet - TradingKey
Renaissance Technologies LLC Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Morningstar Investment Management LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
First Trust Advisors LP Has $49.81 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Acquired by Gabelli Funds LLC - MarketBeat
Kenvue, Inc. Revenue Breakdown – DUS:J4D - TradingView
Healthcare of Ontario Pension Plan Trust Fund Has $62.17 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Absolute Gestao de Investimentos Ltda. Takes Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady after latest earnings and outlook - AD HOC NEWS
Tylenol With Naproxen FDA Approval Could Be A Game Changer For Kenvue (KVUE) - Yahoo Finance
Kenvue (KVUE) Gets An FDA Lift On Tylenol As Valuation Looks Tight - Yahoo Finance UK
Naproxen-Powered Pain Relief Medications: Kenvue Receives FDA Approval for TYLENOL… - Trend Hunter
Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse - Yahoo Finance
5,211,114 Shares in Kenvue Inc. $KVUE Acquired by Kryger Capital LLC - MarketBeat
GABELLI & Co INVESTMENT ADVISERS INC. Raises Holdings in Kenvue Inc. $KVUE - MarketBeat
Bank of Nova Scotia Acquires 816,428 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue, Inc. Revenue Breakdown – FWB:J4D - TradingView
Kenvue, Inc. (KVUE) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
US FDA approves over-the-counter Tylenol combination pill for pain relief - Reuters
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kenvue Inc (KVUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kenvue Inc (KVUE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kenvue Says FDA Has Granted Tylenol Three-Year Exclusivity For New OTC Formulation - TradingView
FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) - Kenvue
Kenvue Inc (KVUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)? - simplywall.st
Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It - The Motley Fool
Kenvue Inc (KVUE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
KVUE|Kenvue Inc|Price:19.477|Chg%:+0.197 - TradingKey
Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Listerine Cool Mint by Kenvuemouthwash classic boosts oral care sales - Ad-hoc-news.de
Capula Management Ltd Grows Position in Kenvue Inc. $KVUE - MarketBeat
Caxton Associates LLP Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Thursday, still outperforms market - MarketWatch
Kenvue to announce Q2 2026 results on August 6, 2026 - scanx.trade
Press Release: Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - 富途牛牛
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - The Joplin Globe
Levin Capital Strategies L.P. Raises Stake in Kenvue Inc. $KVUE - MarketBeat
Technical Reactions to KVUE Trends in Macro Strategies - Stock Traders Daily
Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts - MarketBeat
Kenvue broadens China focus on minor ailment management - China Daily Global Edition
What to expect from Kenvue’s Q2 2026 earnings report - MSN
KBC Group NV Increases Holdings in Kenvue Inc. $KVUE - MarketBeat
SEB Asset Management AB Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Dimensional Fund Advisors LP Has $383.94 Million Position in Kenvue Inc. $KVUE - MarketBeat
The Listerine Cool Mint MouthwashKenvue bets on bold flavor and plaque control - Ad-hoc-news.de
Kenvue stock steadies as consumer health margins lift earnings outlook - Ad-hoc-news.de
Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating - marketscreener.com
What to Expect From Kenvue’s Q2 2026 Earnings Report - Barchart.com
Kenvue Inc. $KVUE Shares Sold by Kapitalo Investimentos Ltda - MarketBeat
Swiss National Bank Has $96.94 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health spin-off builds earnings record - Ad-hoc-news.de
Kenvue Inc. (KVUE) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Kenvue Inc. $KVUE Stake Lifted by Hsbc Holdings PLC - MarketBeat
California Public Employees Retirement System Decreases Stake in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady as the latest report frames 2026 margins - Ad-hoc-news.de
Bank of New York Mellon Corp Sells 223,497 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health margins hold after spin-off - ad-hoc-news.de
Listerine Cool Mint by Kenvue Inc.mouthwash classic fuels recurring sales - ad-hoc-news.de
How Affirmed Talc Successor Liability At Kenvue (KVUE) Has Changed Its Investment Story - simplywall.st
Illinois Municipal Retirement Fund Buys 72,348 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health margins stay in focus - ad-hoc-news.de
0.84%
0.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):